Current role
Biotechnology · Healthcare
Board Member
2020-03-12–present
Gregg Alton
Equibles does not estimate personal net worth.
Get an email with a short summary when Corcept Therapeutics Inc publishes a filing, an earnings call transcript or a press release.
Get CORT alertsAbout Gregg Alton
Gregg Alton is recorded as Board Member at Corcept Therapeutics Inc (CORT) since March 12, 2020. Corcept Therapeutics Inc reported in an 8-K filed May 28, 2026 that Gregg Alton was appointed director, effective May 21, 2026. Corcept Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Corcept Therapeutics Inc includes Joseph K. Belanoff (CEO and Board Member), James N. Wilson (Chairman and Board Member), Atabak Mokari (CFO) and 7 others.
“Gregg Alton | 67,977,943 | 9,316,514 | 15,975,718”
Affiliation history
-
Current
2020-03-12–present
-
Corcept Therapeutics Inc (CORT)
Proxy statement
CurrentStart not stated–present
Last confirmed April 17, 2026
Company network
Leadership on record at Corcept Therapeutics Inc
- Joseph K. Belanoff CEO, Board Member
- James N. Wilson Chairman, Board Member
- Atabak Mokari CFO
- Joshua M. Murray CFO, Head of Investor Relations, Board Member
- Daniel N. Swisher COO
- J.D. Lyon Chief Accounting Officer
- Joseph D. Lyon Chief Accounting Officer
- Daniel N. Swisher, Jr. Board Member
- David L. Mahoney Board Member
- G. Leonard Baker, Jr. Board Member